March 2020 Br J Cardiol 2020;27(suppl 1):S9–S14 doi:10.5837/bjc2020.s03
Jeffrey A Marbach, Aws S Almufleh, Derek So, Aun-Yeong Chong
Introduction Peripheral artery disease (PAD) refers to all arterial disease outside of the coronary arteries and the aorta.1 It is estimated that over 200 million individuals are living with PAD globally.2,3 In the Western world, one in five adults over the age of 75 has PAD, including over 40 million Europeans.3-6 Though the prevalence of PAD is already at endemic levels worldwide, ageing populations and the increasing burden of chronic disease (i.e. hypertension, dyslipidaemia, diabetes mellitus, smoking) will contribute to further increases in the incidence and prevalence of PAD in the coming decades.2,3 As a consequence, PAD is the third
April 2017 Br J Cardiol 2017;24:66-7 doi:http://doi.org/10.5837/bjc.2017.009 Online First
Colin Reid, Mark Tanner, Hatef Mansoubi, Conrad Murphy
Introduction Computed tomography coronary angiography (CTCA) is an established and validated alternative to invasive coronary angiography (ICA).1 The extent to which CTCA can replace ICA is controversial.2 The low diagnostic yield from ICA suggest there is ample scope to select patients more efficiently for investigation.3 In 2010, in the UK, the National Institute for Health and Care Excellence (NICE)4 published new guidelines for the investigation of patients with suspected coronary artery disease (CAD), which incorporated CTCA as a first-line investigation.5 In keeping with these guidelines, we ceased to use exercise testing as a primary t
April 2014 Br J Cardiol 2014;21:77 doi:10.5837/bjc.2014.012 Online First
Colin J Reid, Mark Tanner, Conrad Murphy
Introduction For many years coronary angiography (CA) has been used as the gold standard in the assessment of coronary artery disease (CAD), and even a normal result is considered a worthwhile outcome.1 However, concern has been raised about the use and overuse of what is an invasive and expensive procedure.2-4 We examined our cardiac catheter database to assess our diagnostic yield in terms of detecting CAD, and also in terms of subsequent referral for coronary revascularisation, whether this be by percutaneous coronary intervention (PCI) or coronary artery bypass surgery (CABG), in a population of patients being assessed for possible CAD.
March 2013 Br J Cardiol 2013;20:13
Coronary heart disease is responsible for one sixth of UK deaths. Improvements in making an earlier diagnosis and more effective management have aided a reduction in mortality over the last two decades. Such improvements would not have been possible without well thought-out and carefully constructed guidance and teaching programmes. With the spread of internet technology, online medical education has seen an exponential growth in popularity. The British Journal of Cardiology (BJC) has recently launched its e-learning site BJC Learning and its first e-learning programme on angina (www.bjcardio.co.uk/learning). The angina e-learning programme
October 2011 Br J Cardiol 2011;18:214-215
Michael Norell
Yes, it’s true. After more than 20 years of accessing the arterial circulation almost consistently from the femoral approach, I have given in to the undeniable logic of the trans-radial enthusiasts. Was I among the last of a dwindling minority of dinosaurs, plodding on with traditional practice despite a changing – if not hostile – environment? Technology supporting the radial approach has undoubtedly advanced, and at the same time the interventional landscape has become less attractive to the use of a much larger vessel in which haemostatic control can never be guaranteed. I was wondering how this Damascene change in my practice came a
October 2011 Br J Cardiol 2011;18(Suppl 3):s1-s12 doi:10.5837/bjc.2011.s02
Dr Chris Arden
(more…)
October 2011 Br J Cardiol 2011;18(Suppl 3):s1-s12 doi:10.5837/bjc.2011.s03
Professor Kim Fox
The new guideline from the National Institute for Health and Clinical Excellence (NICE)1 covers adults who have been diagnosed with stable angina due to atherosclerotic disease, following on from clinical guideline 95,2 which advises on diagnosis of chest pain of recent onset. A key priority for implementation in the latest guidance is to ensure that people with stable angina receive balanced information and have the opportunity to discuss the benefits, limitations and risks of their treatment. Initial management of stable angina should be to offer optimal drug treatment, addressing both the angina itself and secondary prevention of cardiovas
November 2009 Br J Cardiol 2009;16:303–4
Khaled Alfakih, Kate Pointon, Thomas Mathew
Figure 1. A short-axis slice of the mid left ventricle illustrating contrast enhancement in the anterior segment (25% transmurality – viable), anterolateral segment (50–75% transmurality – non-viable), inferolateral segment (50% transmurality – potentially viable) Case 1 Mr K P is a 45-year-old man who presented to our hospital with symptoms of exertional breathlessness. His LV function was found to be severely impaired on echocardiography and it was initially thought that he had ‘dilated cardiomyopathy’. As he had a strong family history of coronary artery disease and was an ex-smoker, he underwent X-ray coronary angiography. He
January 2006 Br J Cardiol 2006;13:5-6
Gervasio A Lamas, Steven J Hussein
No content available
November 2005 Br J Cardiol (Acute Interv Cardiol) 2005;12:AIC 81–AIC 82
Khaled Alfakih, Elizabeth Rennie, Stacey Hunter, James Mclenachan
No content available
You need to be a member to print this page.
Find out more about our membership benefits
You need to be a member to download PDF's.
Find out more about our membership benefits